BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15653971)

  • 1. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.
    Foresi A; Mastropasqua B; Chetta A; D'Ippolito R; Testi R; Olivieri D; Pelucchi A
    Chest; 2005 Jan; 127(1):117-24. PubMed ID: 15653971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of adult asthma after normalization of bronchial hyperresponsiveness by inhaled corticosteroid therapy.
    Tsurikisawa N; Tsuburai T; Oshikata C; Ono E; Saito H; Mitomi H; Akiyama K
    J Asthma; 2008 Aug; 45(6):445-51. PubMed ID: 18612895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP.
    Giannini D; Di Franco A; Tonelli M; Bartoli ML; Carnevali S; Cianchetti S; Bacci E; Dente FL; Vagaggini B; Paggiaro PL
    Respir Med; 2003 May; 97(5):463-7. PubMed ID: 12735661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids.
    Godon P; Boulet LP; Malo JL; Cartier A; Lemière C
    Eur Respir J; 2002 Dec; 20(6):1364-9. PubMed ID: 12503690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
    Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
    Di Franco A; Bacci E; Bartoli ML; Cianchetti S; Dente FL; Taccola M; Vagaggini B; Zingoni M; Paggiaro PL
    Pulm Pharmacol Ther; 2006; 19(5):353-60. PubMed ID: 16289980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
    Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
    Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
    Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS
    J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.
    Fujimoto K; Yamaguchi S; Urushibata K; Hanaoka M; Koizumi T; Honda T; Kubo K
    Intern Med; 2006; 45(14):843-9. PubMed ID: 16908940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
    Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
    Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.